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Huntingtin Controls Neurotrophic Support
and Survival of Neurons by Enhancing
BDNF Vesicular Transport along Microtubules
Huntington’s disease (HD). HD is characterized by un-
controlled movements, personality changes, and de-
mentia and causes the death of patients within 10–20
years after the appearance of the first symptoms. The
neuropathology in HD involves a significant dysfunction
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neurons of the striatum. Neuronal loss, however, could1Unite´ Mixte de Recherche 146
be secondary to neuronal dysfunction. In support, motorCentre National de la Recherche Scientifique
and cognitive deficits have been detected in patientsInstitut Curie
and in murine models of HD before any neurodegenera-Building 110
tion is detected (Lione et al., 1999; Smith et al., 2000).Centre Universitaire
The pathogenic mechanisms induced by polyQ-hunt-91405 Orsay Cedex
ingtin (polyQ-htt) are still not clearly understood butFrance
could involve the gain of a new toxic function and/or2 Molecular Neurogenetics Unit
the loss of beneficial activities of wild-type htt (CattaneoMassachusetts General Hospital
et al., 2001; Ross, 2002). Htt is a brain-enriched proteinCharlestown, Massachusetts 02129
that is essential for embryonic development and neuro-3 Institut fu¨r Physiologie und Pathophysiologie
genesis (White et al., 1997; Zeitlin et al., 1995). Htt pos-Johannes Gutenberg-Universita¨t Mainz
sesses antiapoptotic properties, as demonstrated by an55128 Mainz
increased programmed cell death during developmentGermany
in mice lacking htt (Zeitlin et al., 1995). These beneficial
properties of wild-type htt are necessary in adults, as
late inactivation of htt in a conditional mouse modelSummary
leads to progressive neurodegeneration (Dragatsis et
al., 2000). Wild-type htt is protective in neuronal culturesPolyglutamine expansion (polyQ) in the protein hunt-
(Cattaneo et al., 2001) and against death induced byingtin is pathogenic and responsible for the neuronal
polyQ-htt in vivo (Leavitt et al., 2001).toxicity associated with Huntington’s disease (HD). Al-
Although htt is observed in the nucleus, it is predomi-though wild-type huntingtin possesses antiapoptotic
nantly found in the cytoplasm where it associates withproperties, the relationship between the neuroprotec-
vesicular structures and microtubules (MTs). In fact, htttive functions of huntingtin and pathogenesis of HD
associates with various proteins that could play a roleremains unclear. Here, we show that huntingtin specif-
in intracellular trafficking (Harjes and Wanker, 2003). Inically enhances vesicular transport of brain-derived
particular, htt interacts with the huntingtin-associatedneurotrophic factor (BDNF) along microtubules. Hunt-
protein-1 (HAP1), a protein that is transported in axonsingtin-mediated transport involves huntingtin-associ-
and associates with p150Glued dynactin subunit, an es-ated protein-1 (HAP1) and the p150Glued subunit of dy-
sential component of the dynein/dynactin microtubule-nactin, an essential component of molecular motors.
based motor complex (Block-Galarza et al., 1997; Engel-BDNF transport is attenuated both in the disease con-
ender et al., 1997; Li et al., 1995, 1998; Schroer, 1996).text and by reducing the levels of wild-type huntingtin.
Thus, htt could participate in the vesicular transport.The alteration of the huntingtin/HAP1/p150Glued com-
Consistent with these studies, htt and other pathogenicplex correlates with reduced association of motor pro-
polyQ-containing proteins affect fast axonal transport
teins with microtubules. Finally, we find that the polyQ-
(Gunawardena et al., 2003; Szebenyi et al., 2003). How-
huntingtin-induced transport deficit results in the loss ever, the molecular mechanisms leading to defect in
of neurotrophic support and neuronal toxicity. Our transport and the consequences on the degeneration
findings indicate that a key role of huntingtin is to of specific neurons were not established.
promote BDNF transport and suggest that loss of this The antiapoptotic properties and the emerging role
function might contribute to pathogenesis. of htt in intracellular trafficking led us to hypothesize that
htt could play a crucial role in controlling the transport of
Introduction neurotrophic factors. Among these, brain-derived neu-
rotrophic factor (BDNF) is of particular importance for
Polyglutamine repeat expansions are the cause of inher- HD, as BDNF is produced by cortical neurons and trans-
ited neurodegenerative disorders (Ross, 2002) including ported from the cortex to the striatum (Altar et al., 1997),
where it acts as a prosurvival factor for the striatal neu-
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vival by promoting the transport of vesicles containing ported values (Kohara et al., 2001). Expression of wt-FL-
htt induced a significant increase in the mean vesicularBDNF, we analyzed the distribution and dynamics of
BDNF-eGFP-containing vesicles in real time by ultra- velocity, while polyQ-FL-htt did not. We also determined
the pausing time of vesicles corresponding to the timefast 3D videomicroscopy followed by deconvolution.
BDNF-eGFP has biochemical and biological character- vesicles spend without moving and observed that ex-
pression of wt-FL-htt but not polyQ-FL-htt significantlyistics indistinguishable from those of BDNF (Hartmann
et al., 2001; Kohara et al., 2001). We demonstrate here decreased this value (Figure 1E). Analysis of velocity
distribution showed that wt-FL-htt significantly increasedthat htt is a processivity factor that increases the trans-
port efficiency of BDNF-containing vesicles along MTs. the number of vesicles that have a velocity greater than
42m/min (see Supplemental Figure S2 at Cell web site).In the pathological situation, BDNF transport is affected
as polyQ-htt via the HAP1 protein disrupts the associa- To unequivocally confirm that the stimulatory effect
on vesicular transport is due to the presence of htt,tion of key components of the motor machinery to MTs.
Reduced BDNF transport leads to a decrease in neuro- we decreased htt expression by small interfering RNAs
(siRNAs; Figure 1F). Tracking of moving vesicles re-trophic support and to neurotoxicity, which are both
rescued by wild-type htt. These results demonstrate that vealed that a reduction in htt increased the percentage
of static vesicles and reduced their velocities while in-the antiapoptotic properties of htt are linked to the ability
of htt to promote transport of BDNF in the brain. creasing their pausing times (Figures 1G).
Thus, we demonstrate that one function of htt is to
enhance intracellular transport of BDNF-containing ves-Results
icles. This function is altered when htt expression is
reduced or when htt contains the polyQ expansion.Huntingtin Regulates the Dynamics
of BDNF-Containing Vesicles
We first analyzed the distribution of endogenous wild- BDNF Vesicular Transport Is Specifically Altered
in HDtype and polyQ-htt with BDNF in neuronal cell lines de-
rived from knockin mice (Trettel et al., 2000). These cell To establish whether our findings are relevant to HD
pathogenesis, we analyzed BDNF dynamics in primarylines carry either two copies of wild-type htt (wild-type
neuronal cells, /) or two copies of mutant htt (homo- cultures of cortical neurons. In comparison to the control
condition, wt-FL-htt but not polyQ-FL-htt significantlyzygous mutant neuronal cells, 109Q/109Q). 3D deconvo-
lution microscopy revealed a partial colocalization of increased the mean velocity of vesicles (Figure 2A and
Supplemental Movies S1, S2, and S3).endogenous BDNF with htt, but no obvious differences
were found with polyQ-htt (Figure 1A). This partial colo- We next assessed BDNF dynamics in more physiolog-
ical conditions using neuronal cell lines derived fromcalization was confirmed biochemically (see Supple-
mental Figure S1 at http://www.cell.com/cgi/content/ knockin mice where a CAG expansion has been inserted
into the endogenous mouse htt gene (Trettel et al., 2000).full/118/1/127/DC1).
We next examined the effect of htt upon the dynamics These cell lines carry either two copies of wild-type htt
(wild-type neuronal cells, /), one copy of wild-typeof BDNF-containing vesicles using fast 3D videomicros-
copy followed by deconvolution. NG108-15 neuro- htt and one of mutant htt (heterozygous neuronal cells,
/109Q), or two copies of mutant htt (homozygous mu-blastoma cells were transfected with BDNF-eGFP and
either wild-type full-length htt (wt-FL-htt), polyQ-FL-htt tant neuronal cells, 109Q/109Q). These cell lines reflect
the closest situation to HD patients, as, in these cells,or the corresponding empty vector. We monitored the
movement of vesicles by acquiring images in 3D. After wild-type or polyQ-htt are expressed at endogenous
levels. The mean velocity of BDNF vesicles was signifi-deconvolution, a 2D reconstruction of each time point
was performed. The overlapping of vesicles in compari- cantly decreased in /109Q and 109Q/109Q cells com-
pared to / cells (Figure 2B). Interestingly, the alter-son to their previous localization was drastically de-
creased by expression of wt-FL-htt (Figure 1B). In con- ation in transport was similar in heterozygous and
homozygous mutant neuronal cells. This finding is intrast, when htt contained the polyQ expansion, vesicular
movement was comparable to the BDNF-eGFP alone. agreement with the genetic dominance in HD and sug-
gests that mutant polyQ-htt could act in a dominantWe calculated the mean percentage of colocalization of
vesicles between two successive time points (every 1.5 manner to alter transport.
Finally, by ectopically expressing wt or polyQ-FL-htts) for the first ten acquisitions. We found the percentage
of static vesicles to be significantly reduced from 43.3% in 109Q/109Q cells, we tested whether the loss of intra-
cellular transport of BDNF in polyQ-htt condition couldto 23.7% by the expression of wt-FL-htt (Figure 1C).
We tracked BDNF-containing vesicles in NG108-15 be rescued by wild-type htt (Figure 2C). Expression of
wild-type htt increased velocity in 109Q/109Q cells,cells and analyzed the influence of wt or polyQ-FL-htt
on vesicle velocities (Figure 1D). Velocities were deter- while polyQ-htt had no effect.
In addition to htt, polyQ expansion in unrelated pro-mined by comparing the x and y coordinates of one
vesicle every 1 or 2 s over 1 min and were typically teins is the cause of other neurodegenerative disorders,
including spinal and cerebellar ataxias such as SCA3calculated for each condition from two to three indepen-
dent transfections with a total of about 1000–5000 mea- and SCA7. Therefore, we tested the effect of wild-type
and polyQ forms of ataxin-3 and -7 on BDNF transport.sures in 5–17 independent cells. Under control condi-
tions, BDNF vesicles moved at an average velocity of Strikingly, these proteins had neither a stimulatory nor
an inhibitory effect on BDNF transport (Figure 2D). This8.62 m/min, which was comparable to previously re-
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Figure 1. Htt Colocalizes with BDNF and Stimulates BDNF Vesicular Trafficking in Neuronal Cells
(A) Colocalization (yellow) of endogenous BDNF (green) and htt (red, 4E6 antibody) in/ and 109Q/109Q neuronal cells. Similar colocalization
is observed between BDNF and wild-type or polyQ-htt. The small right panels correspond to a 2  enlargement of the boxes present in the
low magnification panels. (B) Overlapping of BDNF vesicles at different time points. Static vesicles appear in yellow and are reduced in the
presence of wt-FL-htt. Scale bar, 5 m. (C) Wild-type htt reduces the percentage of static vesicles. Percentage of static vesicles in control
condition (220 measures, 11 cells), with wt-FL-htt (180 measures, nine cells), and with polyQ-FL-htt (160 measures, eight cells). (D) Wild-type
but not polyQ-htt increases vesicles’ velocities. Mean velocities were calculated without null values that correspond to pauses. (E) Wild-type
but not polyQ-htt decreases the pausing time of BDNF vesicles. Dynamic parameters in (D) and (E) were calculated from 5416 measures for
BDNF-eGFP (13 cells), 3666 measures for wt-FL-htt (16 cells), and 3968 measures for polyQ-FL-htt (11 cells). (F) Transfection of NG108-15
cells with siRNAs directed against mouse htt (siRNA-htt) leads to a significant decrease in htt levels compared to the corresponding scramble
RNA (SC-RNA-htt). (G) Reduction in htt levels increases the percentage of static vesicles and reduces their velocities while increasing their
pausing time (BDNF-eGFP, 2541 measures, nine cells; siRNA-htt, 4047 measures, ten cells; SC-RNA-htt, 2520 measures, eight cells). Statistical
analyses revealed significant differences for mean velocities, pausing, and percentage of static vesicles in NG108-15 cells and in silencing
experiments (*p  0.05, **p  0.01, and ***p  0.001).
result further demonstrates the specificity of htt in the Huntingtin Increases the Efficiency
of Microtubule-Based Transporttransport of BDNF vesicles.
We tested whether transport of other organelles such We next investigated the mechanisms by which htt me-
diates a stimulatory effect on BDNF trafficking. BDNFas mitochondria is affected in HD using a mitochondrial
marker. While 109Q/109Q cells showed a decreased vesicles were localized along MTs and distributed in a
graded fashion from the perinuclear region to the plasmaBDNF vesicular velocity compared to / cells (Figure
2B), the transport of mitochondria was unaffected in HD membrane (Figure 3A). After depolymerizing MTs with
nocodazole, BDNF vesicles were randomly distributed.mutant cells (Figure 2E). Although we can not exclude
that other types of transport are affected in 109Q/109Q In nocodazole-treated cells, BDNF vesicular movement
was completely blocked (Figure 3B), demonstrating thatcells, our findings indicate that the function/dysfunction
of htt is specific, at least in part, to the transport of BDNF. BDNF transport, as observed in our experimental condi-
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Figure 2. BDNF Transport Is Specifically Altered in Huntington’s Disease and Is Rescued by Expression of Wild-Type htt
(A) Wt-FL-htt but not polyQ-FL-htt increases the mean velocity of BDNF-containing vesicles and decreases their pausing time in primary
cultures of cortical neurons (BDNF-eGFP, 1330 measures, 11 cells; wt-FL-htt: 2020 measures, ten cells; or polyQ-FL-htt, 477 measures, three
cells) (see Supplemental Movies S1, S2, and S3). (B) Mean velocities of moving vesicles are altered in /109Q cells (7780 measures, 25 cells)
and 109Q/109Q cells (5066 measures, 23 cells) in comparison to / cells (4168 measures, 17 cells). (C) BDNF transport deficiency in 109Q/
109Q cells (2040 measures, nine cells; 2106 measures, eight / cells) is restored by the expression of wt- (2360 measures, eight cells) but
not polyQ-FL-htt (2456 measures, eight cells). (D) BDNF transport is not altered by other polyQ-disorder proteins. Velocity of BDNF vesicles
is not modified in NG108-15 cells transfected with wt-FL-ataxin-7 (2729 measures, eight cells) or polyQ-ataxin-7 (3698 measures, nine cells)
or in cells expressing either truncated polyQ-ataxin-3 (2746 measures, seven cells), wt-FL-ataxin-3 (2319 measures, six cells), or polyQ-
ataxin-3 (3551 measures, eight cells). Control, 2354 measures, seven cells; and wt-FL-htt, 1908 measures, five cells. (E) Mitochondrial dynamic
is not altered in HD mutant neuronal cells (/ cells, 7557 measures, 16 cells; 109Q/109Q cells, 7211 measures, 25 cells) (*p  0.05, **p 
0.01, and ***p  0.001).
tions, is an MT-based transport. It is worth noting that roblastoma cells expressing wt-FL-htt than in control
cells or cells expressing polyQ-FL-htt (Figure 3C), indi-the alteration in BDNF transport in HD cells is unlikely
to be the consequence of a major polyQ-induced cy- cating that wt-FL-htt induces a more direct transport of
vesicles along the MT network. Second, we calculatedtoskeletal disorganization, as actin and MT networks as
well as the distal end of the growing MTs were compara- the effect of htt on the distance traveled by vesicles
between two pauses. This parameter was used to dem-ble between / and 109Q/109Q cells (Supplemental
Figure S3). onstrate that dynactin is a processivity factor for the
cytoplasmic motor protein dynein (King and Schroer,In order to quantify transport efficiency along MTs,
we investigated the influence of htt on two parameters. 2000). When expressing the mean velocity as a function
of the distances, wt-FL-htt increased the distance trav-The first one, “persistence,” relies on the ability of a
given organelle to move and persist in a directional eled between two pauses independently of velocity (Fig-
ure 3D). By contrast, polyQ-FL-htt had no effect. In con-movement and is calculated as the ratio between the
total distance covered by the particle and the shortest clusion, this demonstrates that a function of htt is to
enhance the efficiency of BDNF vesicles transportpossible distance between its initial and final points
(Cordonnier et al., 2001). Persistence was lower in neu- along MTs.
Huntingtin Transports BDNF
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Figure 3. Wt- but Not polyQ-FL-htt Increases
the Efficiency of MT-Based Transport
(A) Immunostaining for BDNF and -tubulin
in neuronal cells without (upper panels) and
with nocodazole treatment (lower panels).
Scale bar, 5 m. (B) Nocodazole treatment
significantly reduces the mean velocity of
moving vesicles in / neuronal cells (con-
trol, 1218 measures, five cells; Noco, 2188
measures, four cells). (C) Persistence of
BDNF vesicles is reduced in cells transfected
with BDNF-eGFP and wt-FL-htt (117 tracks,
17 cells) in comparison to cells transfected
with BDNF-eGFP and polyQ-FL-htt (83
tracks, 11 cells) or with BDNF-eGFP alone
(108 tracks, 12 cells). (D) Scatter plots of the
translocation velocities of BDNF-containing
vesicles as a function of the distance traveled
between two pauses. (E) Htt enhances BDNF
transport in neurites and in cell bodies of cor-
tical neurons. Parameters in cell body and
neurites are, respectively, from BDNF-eGFP,
796 and 381 measures in five cells; wt-FL-
htt, 1239 measures, ten cells; 564 measures,
eight cells; and polyQ-FL-htt, 208 and 248
measures, three cells. (F) Htt stimulates out-
ward/anterograde and inward/retrograde
movements in cortical neurons. Outward and
inward parameters are, respectively, from
BDNF-eGFP, 238 and 143 measures, five
cells; wt-FL-htt, 281 measures, eight cells;
283 measures, seven cells; and polyQ-FL-htt,
116 and 132 measures, three cells (*p 0.05,
**p  0.01, and ***p  0.001).
We next investigated BDNF dynamics in cell body tracking protein (Stepanova et al., 2003). In agreement
with previous studies, 70%–80% of the observed EB3versus neurites in cortical neurons (Figure 3E). While htt
stimulated BDNF transport both in neurites and in cell displacements in neurons were toward the tips of the
neurites (data not shown), strongly indicating that mostbodies, this stimulatory effect was especially evident in
neurites. As we observed the movements of BDNF to of the outward and inward movements correspond to
anterograde and retrograde movements, respectively,be bidirectional (see Supplemental Movie S4), we also
asked whether, in neurites, transport was selectively according to the MTs’ organization.
regulated by htt in one or both directions. In axons, MTs
are orientated unidirectionally with all plus ends pointing Huntingtin-Mediated Vesicular Transport
Requires HAP1toward the growth cone. However, in dendrites, MTs
are organized in both directions with plus ends pointing Htt interacts with HAP1, which could play a role in intra-
cellular transport. We analyzed the consequences ofboth distally and toward the cell body (Baas et al., 1988).
As we could not distinguish between axons and den- HAP1 expression on BDNF-eGFP dynamics. Strikingly,
HAP1 specifically induced a dramatic redistribution ofdrites in our assay, we determined the velocity of BDNF
vesicles moving toward the tips of the neurites (outward) BDNF-containing vesicles into large cytoplasmic bodies
with a partial to complete disappearance of individualor moving to the cell body (inward) (Figure 3F). Htt en-
hanced the velocity of BDNF vesicles that moved out- vesicles (Figure 4A and Supplemental Figure S4). HAP1
was localized at the periphery of these BDNF immunore-ward or inward, and both movements were affected
equally by polyQ. To relate the outward/inward move- active cores. These structures resembled HAP1-con-
taining organelles, described as stigmoid bodies in nor-ment to the organization of the MT network in axons and
dendrites, we analyzed the directionality of MT growth mal brains (Gutekunst et al., 1998) (Supplemental Figure
S5). HAP1 induced the recruitment of wt- or polyQ-FL-in cortical neurons using end binding protein 3 (EB3)
coupled to GFP. EB3 is neuron-specific plus end- htt and p150Glued into these BDNF-containing bodies (Fig-
Cell
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Figure 4. HAP1 Is Required for htt-Mediated Transport of BDNF
(A) HAP1 delocalizes BDNF-containing vesicles. NG108-15 cells were transfected with BDNF-eGFP and HAP1 or its corresponding empty
vector and immunostained for BDNF (green) and HAP1 (red). (B) HAP1/BDNF-containing bodies recruit htt. NG108-15 cells were cotransfected
with BDNF-eGFP, HAP1, and wt- or polyQ-FL-htt and immunostained for BDNF (green) and htt (red). The right panels in (A) and (B) correspond
to a 6  enlargement of the small boxes present in the merge panels. (C) p150Glued and BNDF-eGFP are relocalized when coexpressed with
HAP1. Compare subcellular distribution of p150Glued (red) and BNDF (green) in the absence (upper panels) or presence of HAP1 (lower panels).
The right panels correspond to a 6  enlargement of the small boxes present in the merge panels. (D) HAP1 induces the relocalization of
BDNF (green) but not of mitochondria (red). Scale bar, 5 m. (E) Exon1 of htt does not interact with HAP1. GST-HAP1 pull-down experiments
were performed with the first 480 amino acids of htt or with the wt- and polyQ-exon1 fragments. (F) Exon1 of htt does not stimulate transport.
Mean velocities of moving vesicles in NG108-15 cells after transfection with wt-FL-htt (2645 measures, nine cells), wt-exon1-htt (3425 measures,
11 cells), or polyQ-exon1-htt (4442 measures, 12 cells). Control, 3633 measures, nine cells. (G) Transfection of NG108-15 cells with siRNAs
directed against HAP1 (siRNA-HAP1) but not corresponding scrambled RNA (SC-RNA-HAP1) leads to a significant decrease in HAP1 levels.
(H) Reduction in HAP1 levels reduces BDNF velocity and blocks the htt-induced stimulation of transport. Velocities were calculated from 2808
measures for BDNF-eGFP (eight cells), siRNA-HAP1 (2178 measures, eight cells), SC-RNA-HAP1 (1491 measures, seven cells), wt-FL-htt (2152
measures, eight cells), wt-FL-htt and siRNA-HAP1 (2853 measures, nine cells), and wt-FL-htt and SC-RNA-HAP1 (2664 measures, nine cells)
(**p  0.01 and ***p  0.001).
ures 4B and 4C) but had no effect on mitochondria that HAP1 is essential for the stimulatory effect of htt
on BDNF trafficking.(Figure 4D). Finally, the formation of the HAP1-induced
BDNF bodies depended on the integrity of the MT net-
work and was minus end-directed as sensitive to the Huntingtin/HAP1/p150Glued Dynactin Complex
Is Altered in HDoverexpression of p50/Dynamitin (Supplemental Fig-
ures S6 and S7). The finding that HAP1, htt, and p150Glued relocalized in
the BDNF-containing bodies led us to assess the statusWe sought to establish whether truncated versions of
htt that do not interact with HAP1 still activate transport of these proteins in the pathological situation by sucrose
gradient fractionation. Cytosolic cell extracts from /of BDNF. In contrast to an N-terminal fragment of htt
containing the first 480 amino acids, exon1 of htt (first and 109Q/109Q cells were fractionated on a linear su-
crose gradient (7.5%–25%). Wild-type htt comigrated67 amino acids) did not bind HAP1 (Figure 4E) (Bertaux
et al., 1998) and had no effect on transport (Figure 4F). with p150Glued and dynein, suggesting that a fraction of
soluble wild-type htt is present in the p150Glued/dyneinFinally, htt-mediated stimulation of transport was
blocked when HAP1 protein levels were reduced by complex (Figure 5A) (Li et al., 1998). In addition, we also
found a peak of htt in lower-density fractions, indicatingsiRNA (Figures 4G and 4H). These results demonstrate
Huntingtin Transports BDNF
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Figure 5. Htt/HAP1/p150Glued Complex Is Altered in HD
(A) Comigration of htt with p150Glued and dynein in sucrose gradients is modified by polyQ expansion in 109Q/109Q cells, in brain from /109Q
mice, and in brain from HD patients (two HD individuals were tested). (B) Htt binds p150Glued via HAP1. Extracts from cells transfected
with 480-17Q and siRNA-HAP1 or corresponding scramble were immunoprecipitated (IP) using an anti-htt antibody, revealing a decreased
immunoprecipitation of p150Glued when HAP1 levels are decreased. (C) Interaction of htt and p150Glued is enhanced by the polyQ expansion.
GST-HAP1 pull-down experiments were performed in the presence or absence of p150Glued and wild-type or polyQ-htt. The graph represents
the quantitative assessment of htt (n  4) and p150Glued (n  3) binding to HAP1. (D) Immunoprecipitation experiments in 109Q/109Q cells
show enhanced interaction of p150Glued with polyQ-htt. Cell extracts were immunoprecipitated using anti-htt or anti--galactosidase (control)
antibodies and immunoprobed with anti-htt or anti-p150Glued antibodies. The graph represents the quantitative assessment of the optical
density of p150Glued and htt and is expressed as a p150Glued/htt ratio (n  4) (*p  0.05).
that htt may also exist as a free component of this com- interaction depended on the presence of HAP1 (Figure
5B), showing that htt forms a complex in cells withplex. Interestingly, in the pathological situation, most of
polyQ-htt sedimented in these lower-density fractions. p150Glued via HAP1.
We next analyzed the influence of the polyQ expan-We confirmed this result in more physiological situations
in HD mice and in HD individuals. In HD patients, a shift sion on the htt/HAP1/p150Glued complex. PolyQ-htt
bound HAP1 with a higher affinity compared to wild-in the migration of dynein IC compared to p150Glued was
observed, suggesting a disruption of the dynein/dynac- type htt (Figure 5C) (Li et al., 1995). Strikingly, p150Glued
binding to HAP1 was also increased when htt containedtin complex. Together, our results in cellular and mouse
models of HD as well as in HD patients suggest that the pathological expansion. In a more physiological situ-
ation, the ability of anti-htt antibodies to immunoprecipi-p150Glued, htt, and dynein may be involved in the same
cytoplasmic protein complex and that this complex is tate the p150Glued protein was enhanced in the 109Q/
109Q neuronal cells in comparison to wild-type cellsaltered in HD.
We examined whether htt binds to p150Glued and whether (Figure 5D). We also observed this enhanced binding of
p150Glued to htt in postmortem brain extracts from HDthis binding is direct or requires HAP1 by immunoprecipi-
tation experiments. Htt interacted with p150Glued, and this patients compared to control individuals (data not
Cell
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Figure 6. PolyQ Expansion Inhibits htt, HAP1,
and Motor Proteins’ Association to MTs
(A) Htt and HAP1 association to MTs is re-
duced by polyQ expansion. MT preparations
from cells expressing wt-FL-htt or polyQ-FL-
htt in absence (left panel) or in presence of
HAP1 (right panel) were immunoprobed for
htt, -tubulin, and HAP1. S and P, superna-
tant and pellet fractions.
(B) Htt and motor proteins do not associate
to MTs in HD neuronal cells. MT preparations
from / or 109Q/109Q cells were analyzed
for the presence of htt, p150Glued, dynein IC,
kinesin HC, and -tubulin.
(C) Htt’s function in transport.
shown). In conclusion, the presence of polyQ expansion dazole had no effect on the amount of BDNF released
after depolarization (Figure 7A). To specifically test thein htt leads to an increased interaction between polyQ-
htt, HAP1, and p150Glued proteins. effect of transport on BDNF release, cells were depolar-
ized, treated with nocodazole for 30 min, and depolar-
ized a second time (Figure 7B). In control cells, a recov-PolyQ-Huntingtin Inhibits HAP1/p150Glued Dynactin
ery period of 30 min was sufficient to reconstitute aBinding to Microtubules
releasable pool similar to the first one (Figures 7C andWe next assessed the association of htt to MTs by pre-
7D). However, in the nocodazole-treated cells, the re-paring taxol-stabilized MT fractions. Htt was mainly found
lease of BDNF was completely inhibited. This resultin the supernatant fraction, but a significant percentage
shows that inhibition of BDNF transport abrogates thewas found in the pellet fraction (Figure 6A, left panel)
ability of cells to refill the releasable pool of BDNF vesi-(Hoffner et al., 2002; Tukamoto et al., 1997). PolyQ-htt
cles following depolarization.was not detectable in the pellet fraction. We analyzed
Having established the experimental conditions tothe distribution of HAP1 to MTs by cotransfecting cells
assay a BDNF release that is strictly dependent uponwith htt and HAP1. While HAP1 was normally enriched
transport, we investigated the effect of polyQ expansion.in the pellet fraction, a significant fraction of HAP1 redis-
To make sure that the observed effect on BDNF releasetributed to the supernatant fraction in the presence of
was not due to a defect in BDNF production, we ectopi-polyQ-htt (Figure 6A, right panel).
cally expressed BDNF under the control of CMV pro-Using 109Q/109Q cells, we found that binding of en-
moter and found similar levels of intracellular BDNFdogenous htt and p150Glued to MTs was reduced (Figure
in / and 109Q/109Q cells (data not shown). We next6B). In addition, the association of key proteins of the
measured in these cells the release of BDNF as in Figuremolecular motor complexes such as dynein intermedi-
7B. While the amount of BDNF released after K1 wasate chain (IC) and kinesin heavy chain (HC) to MTs was
similar between / and 109Q/109Q cells, the amountcompromised in homozygous mutant cells.
of BDNF in K2 was significantly reduced in mutant cells,These results demonstrate that the increased binding
resulting in a decreased K2/K1 release ratio (Figure 7E).of polyQ-htt to HAP1 leads to a reduced association of
This demonstrates that 109Q/109Q cells present a trans-key components of the motors to MTs (Figure 6C). As
port-dependent deficit of BDNF release.these components play a crucial role in regulating trans-
port along the MTs, this reduced association to MTs is The alteration in the transport of BDNF in 109Q/109Q
likely to be responsible for the decreased transport of cells is rescued by wt-FL-htt (Figure 2C). Therefore, we
BDNF-containing vesicles. investigated whether expression of wt-FL-htt in 109Q/
109Q cells can also rescue the defect of BDNF release.
In contrast to the expression of polyQ-htt, expression ofThe PolyQ-Huntingtin-Induced Transport Deficit Results
wild-type htt restored the ability of 109Q/109Q neuronalin a Loss of Neurotrophic Support and Toxicity:
cells to release BDNF (Figure 7E). We conclude that, inRescue by Wild-Type Huntingtin
HD cells, the loss of htt function in the transport ofWe addressed the consequences of an altered MT-
BDNF vesicles results in the inability of these cells todependent transport on the ability of neuronal cells to
release BDNF by treating cells with nocodazole. Noco- release BDNF.
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Figure 7. Disruption of htt-Mediated Transport of BDNF Results in a Loss of BDNF Release and an Increased Cell Death that Are Both Rescued
by Wild-Type htt
(A) BDNF release after KCl-induced depolarization is not affected by nocodazole treatment. (B) Description of the protocol used to assess
the transport-dependent release of BDNF. (C) Transport-dependent BDNF release is significantly blocked by nocodazole treatment. (D)
Transport-dependent BDNF release can also be represented as a K2/K1 ratio. (E) Transport-dependent BDNF release is reduced in 109Q/
109Q neuronal cells and is rescued by expression of wt but not polyQ-htt. (F) BDNF levels are reduced in the striatum but not in the cortex
of HD patients. Representative immunoblots of BDNF and actin are shown. Graphs represent the normalized BDNF protein levels in the cortex
(upper graph, CT, n  3; HD, n  10) and in the striatum (lower graph, CT, n  7; HD, n  10). (G) Neuronal death is statistically increased
in 109Q/109Q neuronal cells and is rescued by expression of wt but not polyQ-htt (*p  0.05, **p  0.01, and ***p  0.001).
To confirm our hypothesis, we determined BDNF lev- p150Glued, dynein IC, and kinesin HC from MTs. p150Glued
and dynein IC are key components of the molecularels in cortical and striatal postmortem brain extracts
from control and HD patients. BDNF levels were reduced motors (Vale, 2003). Indeed, dynactin is a factor that
regulates the processivity of the cytoplasmic dynein.in the striatum but not in the cortex of HD patients (Figure
7F) (Ferrer et al., 2000). This is in agreement with a In vitro, addition of dynactin to dynein increases the
motility of polystyrene beads along MTs while this move-defect in the transport of BDNF by the cortico-striatal
projecting neurons. ment is reduced by incubation with anti-p150Glued anti-
bodies (King and Schroer, 2000). Therefore, a reductionOur findings of the reduced transport and subsequent
reduced release in BDNF led us to investigate whether in the amount of these proteins at the MTs is likely to
decrease intracellular transport. In support, disruptionhomozygous mutant neuronal cells are more suscepti-
ble to death and whether cell death can be rescued by of the dynein/dynactin complex by overexpression of
the p50 dynamitin or mutations in dynein cause axonaloverexpressing wt-FL-htt. We observed a statistically
significant increased cell death in 109Q/109Q cells in transport inhibition and neurodegeneration in mouse
(Burkhardt et al., 1997; Hafezparast et al., 2003; LaMontecomparison to / cells (Figure 7G). Moreover, wild-
type but not polyQ-htt rescued cell death in 109Q/ et al., 2002). Moreover, the inability of dynactin to bind
to MTs is responsible for an autosomal dominant form of109Q cells.
lower motor neuron disease in humans (Puls et al., 2003).
We also observed a reduced association of kinesinDiscussion
HC to MT in HD knockin mouse. Kinesins are motor
proteins responsible for anterograde movement of vari-Huntingtin Controls Anterograde and Retrograde
Transport of BDNF Vesicles ous cargoes (Kanai et al., 2000). This is in agreement with
our observation that htt stimulates both anterograde andWe demonstrate that the increased association of polyQ-
htt to HAP1 and p150Glued leads to the depletion of HAP1, retrograde transport of BDNF vesicles (Figure 3F and
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Supplemental Movie S4). Interestingly, a cDNA encoding nance in HD, we found the alteration in transport to be
a human kinesin-like protein was pulled down by the similar in heterozygous and homozygous neuronal cells.
yeast two-hybrid system using HAP1 as bait (Engelender We could not observe such dominant effect of polyQ-
et al., 1997). We subsequently found this cDNA to be htt in overexpressing conditions (compare Figures 1D
99% identical to the human kinesin heavy chain isoform and 2A to Figure 2B). This discrepancy might be related
5C, a neuron-specific kinesin (Kanai et al., 2000). Thus, to the experimental conditions. Indeed, in contrast to
HAP1 could directly interact not only with p150Glued but overexpressing cells, neuronal cells generated from
also with kinesins and, as demonstrated for p150Glued knockin HD mice express wild-type and mutant htt at
itself (Deacon et al., 2003), participate in both the antero- endogenous levels and thus reflect more closely the
grade and retrograde transport of vesicles. pathological situation observed in HD patients. In good
Our observation that expression of HAP1 clusters agreement, our biochemical experiments demonstrate
BDNF vesicles but not mitochondria supports the notion that polyQ-htt depletes motor proteins from MTs simi-
that htt specifically stimulates transport of BDNF. Inter- larly in homozygous cells and HD patients. In conclusion,
estingly, overexpression of Milton, a Drosophila ortholog htt is a positive regulator of BDNF transport, and abnor-
of HAP1 (Stowers et al., 2002), leads to the redistribution mal polyQ expansion in htt results in the loss of its
of mitochondria. Therefore, HAP1 and Milton show function in transport by a dominant effect.
specificity in the type of cargoes they are transporting. A key step during the cascade of molecular events
This also suggests the existence in human of an HAP1 leading to the death of neurons in the brain is the cleav-
homolog that could specifically transport mitochondria. age of htt into smaller N-terminal fragments. Indeed,
htt is the substrate of several proteases that generate
PolyQ-Induced Loss of htt Function various N-terminal fragments containing the expanded
and Axonal Poisoning polyQ stretch (DiFiglia, 2002). We show that a N-terminal
Our results are consistent with studies that demon- fragment of htt corresponding to exon1 is unable to
strated an alteration of transport by polyQ-containing stimulate intracellular transport of BDNF-containing
proteins (Gunawardena et al., 2003; Lee et al., 2004; vesicles. Therefore, one of the consequences of wild-
Piccioni et al., 2002; Szebenyi et al., 2003). Indeed, the type htt proteolysis could be to inactivate the function
authors proposed that axonal transport could be af- of htt in transport. These results are consistent with the
fected by at least two mechanisms. One could be spe- observations that truncated htt has lost its antiapoptotic
cific to the function of htt in intracellular transport, and properties (Cattaneo et al., 2001). As proteolysis of nor-
the other mechanism could be general to all polyQ-
mal htt is also observed in HD brains (DiFiglia, 2002),
containing proteins and would involve axonal blockage
this cleavage, by reducing BDNF transport and thus
(i.e., axonal poisoning). Here, we dissected the molecu-
neurotrophic supply, could enhance the neurodegener-
lar mechanisms by which htt controls intracellular trans-
ation induced by the polyQ expansion in the mutantport of BDNF. We believe these specific mechanisms
allele.to be distinct from those involved in axonal poisoning
for several reasons. First, we observed this deficit in
transport only with htt and not with other polyQ-con-
Antiapoptotic Properties of Huntingtintaining proteins. Second, in our experiments, no micro-
BDNF that is provided by cortico-striatal projections isscopically visible aggregates could be detected (data
essential for the survival of striatal neurons in normalnot shown), suggesting that soluble polyQ-htt is unable
and pathological situation (Altar et al., 1997; Baquet etto stimulate transport. Finally, we found that wt-FL-htt
al., 2004; Saudou et al., 1998). Therefore, a reduction instimulates transport while a reduced intracellular trans-
the transport of BDNF in cortical neurons that has aport is observed after RNA interference. These experi-
direct consequence on the ability of these cells to re-ments were performed independently of the pathologi-
lease BDNF will be deleterious for striatal neurons. Incal context. They further support a role for wild-type
support, the amount of BDNF is reduced in the striatumhtt in intracellular transport and that this function is
but not in the cortex of HD patients (Ferrer et al., 2000)mitigated in the disease situation.
(Figure 7F).Our results suggest that, in the early course of the
Our results are consistent with the findings that wt-disease, the function of htt in transport is lost via a direct
FL-htt but not polyQ-FL-htt (or N-terminal fragments)effect of the polyQ expansion on the ability of htt to
possesses antiapoptotic properties (Cattaneo et al.,interact properly with the HAP1 protein. In later stages
2001). These antiapoptotic properties have been linkedof the disease, neuritic aggregates accumulate and will
to an increased BDNF transcriptional activity (Zuccatoalso contribute to reduce axonal transport. Finally, our
et al., 2001) but could also be related to the capacity ofobservation that transport is reduced but not completely
the wt-FL-htt protein to increase the transport of BDNF.blocked or stopped is in agreement with the fact that, in
Our findings that intracellular transport is rescued byHD, disease progresses several years before symptoms
wt-FL-htt but not polyQ-FL-htt suggest that the mea-appear in patients.
surement of BDNF transport by 3D fast videomicros-
copy could be used to screen for compounds able toLoss of htt’s Function in Transport by polyQ
restore htt function in transport. The identification ofExpansion and Proteolysis
such compounds might be of therapeutic interest and/We have demonstrated that polyQ-htt acts in a dominant
or help in the design of strategies for early therapeuticmanner to alter transport in heterozygous neuronal cells
for HD mutation. In agreement with the genetic domi- interventions in HD.
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